...
首页> 外文期刊>Vaccine >Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor
【24h】

Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor

机译:在一次性中空纤维生物反应器中培养带有粘附和悬浮MDCK细胞的高滴度人甲型流感病毒

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Hollow fiber bioreactors (HFBRs) have been widely described as capable of supporting the production of highly concentrated monoclonal antibodies and recombinant proteins. Only recently HFBRs have been proposed as new single-use platforms for production of high-titer influenza A virus. These bioreactors contain multiple hollow fiber capillary tubes that separate the bioreactor in an intra- and an extra-capillary space. Cells are usually cultured in the extra-capillary space and can grow to a very high cell concentration. This work describes the evaluation of the single-use hollow fiber bioreactor PRIMER HF (R) (Biovest International Inc., USA) for production of influenza A virus. The process was setup, characterized and optimized by running a total of 15 cultivations. The HFBRs were seeded with either adherent or suspension MDCK cells, and infected with influenza virus A/PR/8/34 (H1N1), and the pandemic strain A/Mexico/4108/2009 (H1N1). High HA titers and TCID50 of up to 3.87 log(10) (HA units/100 mu L) and 1.8 x 10(10) virions/mL, respectively, were obtained for A/PR/8/34 influenza strain. Influenza virus was collected by performing multiple harvests of the extra-capillary space during a virus production time of up to 12 days. Cell-specific virus yields between 2,000 and 8,000 virions/cell were estimated for adherent MDCK cells, and between 11,000 and 19,000 virions/cell for suspension MDCK.SUS2 cells. These results do not only coincide with the cell-specific virus yields obtained with cultivations in stirred tank bioreactors and other high cell density systems, but also demonstrate that HFBRs are promising and competitive single-use platforms that can be considered for commercial production of influenza virus
机译:中空纤维生物反应器(HFBR)已被广泛描述为能够支持高浓度单克隆抗体和重组蛋白的生产。直到最近,才提出将HFBR作为生产高滴度甲型流感病毒的新的一次性平台。这些生物反应器包含多个中空纤维毛细管,在毛细管内和毛细管外空间将生物反应器分开。细胞通常在毛细血管外空间中培养,并且可以生长到非常高的细胞浓度。这项工作描述了用于生产甲型流感病毒的一次性中空纤维生物反应器PRIMER HF(R)(美国Biovest International Inc.)的评估。通过总共进行15次培养来设置,表征和优化该过程。将HFBRs接种粘附或悬浮的MDCK细胞,并感染流感病毒A / PR / 8/34(H1N1)和大流行毒株A / Mexico / 4108/2009(H1N1)。对于A / PR / 8/34流感病毒株,分别获得高达3.87 log(10)(HA单位/ 100μL)和1.8 x 10(10)病毒体/ mL的高HA滴度和TCID50。流感病毒是通过在长达12天的病毒生产时间内多次收获毛细管外空间来收集的。对于粘附的MDCK细胞,估计细胞特异性病毒产量为2,000至8,000个病毒粒子/细胞,对于悬浮的MDCK.SUS2细胞,估计为11,000至19,000个病毒粒子/细胞。这些结果不仅与在搅拌釜生物反应器和其他高细胞密度系统中培养获得的细胞特异性病毒产量相符,而且还证明了HFBR是有前途和有竞争力的一次性平台,可用于商业生产流感病毒

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号